Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Medicinal chemical properties of successful central nervous system drugs
Authors
Hassan Pajouhesh
George R. Lenz
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 4/2005
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1602/neurorx.2.4.541

Other articles of this Issue 4/2005

Neurotherapeutics 4/2005 Go to the issue

OriginalPaper

Challenges in the development of novel treatment strategies for neuropathic pain

OriginalPaper

The quest for market exclusivity in biotechnology: Navigating the patent minefield

OriginalPaper

New prospects and strategies for drug target discovery in neurodegenerative disorders

OriginalPaper

Translational research in central nervous system drug discovery

OriginalPaper

Innovative approaches for the development of antidepressant drugs: Current and future strategies

Editorial

Drug discovery for disorders of the central nervous system